Research study Program year 2019 Source: CMS Open Payments

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults 50 Years of Age or Older PNEU-AGE

Research payments

$61,620

85 payments

Through program year 2019, $61,620 in research payments was reported against A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults 50 Years of Age or Older PNEU-AGE, across 85 payments, paid by Merck Sharp & Dohme Corporation.

Paid by: Merck Sharp & Dohme Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$61,620	85

Breakdown

Who paid Research payments · program year 2019

Merck Sharp & Dohme Corporation $61,620 85 payments

Who received the money Research payments · program year 2019

Synexus Organisation paid for research $7,715 7 payments
Indago Research And Health Center, INC Organisation paid for research $5,851 10 payments
Advanced Medical Research Institute Organisation paid for research $5,646 9 payments
Artemis Institute For Clinical Research Organisation paid for research $4,768 10 payments
Health Research of Hampton Roads, Inc. Organisation paid for research $4,754 7 payments
Research Centers of America, LLC Organisation paid for research $4,665 8 payments
Charlottesville Medical Research Center, LLC Organisation paid for research $4,266 4 payments
Diagnostics Research Group Organisation paid for research $4,235 6 payments
Lakes Research LLC Organisation paid for research $4,222 5 payments
Alliance for Multispecialty Research, LLC Organisation paid for research $4,080 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.